News & Events

News

The supercar stays in the garage: Why advanced methods for comparing new treatments are used infrequently, and what regulators should do about it

Crises of Confidence: September 11th vs. Coronavirus

The societal perspective in cost-effectiveness analysis: ICER has done its part. Now it’s industry’s turn to step up.

View All News Items

Events

12:00–1:00 on January 27, 2020: Health Policy Seminar with Aaron Schwartz, MD, PhD

12:00–1:00 on December 11, 2019: Health Policy Seminar with Anirban Basu, PhD, MS

12:00–1:00 on November 14, 2019: Health Policy Seminar with Joey Mattingly, PharmD, MBA, PhD

View All Events

Publications

What types of real-world evidence studies do U.S. commercial health plans cite in their specialty drug coverage decisions?

The supercar stays in the garage: Factors preventing indirect comparisons of novel medicines targeting the same condition

Comparing inpatient costs of heart failure admissions for patients with reduced and preserved ejection fraction with or without type 2 diabetes

View All Publications